McGann M, Sacco A, Barnachea L. Evaluation of Extended-Release Oxycodone Administered through Enteral Tubes for the Management of Pain in Patients with Head and Neck Cancer: A Case Series [published online ahead of print, 2021 Sep 10]. J Pain Palliat Care Pharmacother. 2021;1-6. doi:10.1080/15360288.2020.1830224

Takemura M, Niki K, Okamoto Y, et al. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone. Biol Pharm Bull. 2021;44(9):1286-1293. doi:10.1248/bpb.b21-00212

Überall MA, Elling C, Eibl C, et al. Tapentadol prolonged release in patients with chronic low back pain: real-world data from the German Pain eRegistry [published online ahead of print, 2021 Aug 11]. Pain Manag. 2021;10.2217/pmt-2021-0058. doi:10.2217/pmt-2021-0058

Sloan G, Alam U, Selvarajah D, Tesfaye S. The Treatment of Painful Diabetic Neuropathy [published online ahead of print, 2021 Jul 6]. Curr Diabetes Rev. 2021;10.2174/1573399817666210707112413. doi:10.2174/1573399817666210707112413